Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Queensland Health
McKinsey
Boehringer Ingelheim
Chinese Patent Office
Medtronic
Federal Trade Commission
Covington

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072213

« Back to Dashboard

NDA 072213 describes PANCURONIUM BROMIDE, which is a drug marketed by Elkins Sinn, Hospira, Igi Labs Inc, and Teva Pharms Usa, and is included in eleven NDAs. It is available from one supplier. Additional details are available on the PANCURONIUM BROMIDE profile page.

The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pancuronium bromide profile page.
Summary for 072213
Tradename:PANCURONIUM BROMIDE
Applicant:Igi Labs Inc
Ingredient:pancuronium bromide
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 072213

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2MG/ML
Approval Date:Mar 31, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Baxter
Fuji
Julphar
Chubb
US Department of Justice
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.